Ryota Nishimori
President bij CAC HOLDINGS CORPORATION
Vermogen: 623 212 $ op 31-03-2024
Profiel
Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAC HOLDINGS CORPORATION
0.23% | 31-12-2022 | 48 000 ( 0.23% ) | 623 212 $ | 31-03-2024 |
Actieve functies van Ryota Nishimori
| Bedrijven | Functie | Begin |
|---|---|---|
| CAC HOLDINGS CORPORATION | President | 01-01-2021 |
CAC KK
 CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | President | 01-04-2014 |
Eerdere bekende functies van Ryota Nishimori
| Bedrijven | Functie | Einde |
|---|---|---|
| CAC America Corp. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CAC HOLDINGS CORPORATION | Technology Services |
| Bedrijven in privébezit | 2 |
|---|---|
| CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |
